[1]胡显文, 陈惠鹏, 张数庸. 全球生物制药产业概况[J]. 中国医药生物技术, 2009, 4(2):85-89. [2]张洁, 张松. 单克隆抗体药物的研究进展[J]. 中国药业, 2006, 15(14):61-62. [3] 张元兴. 动物细胞培养工程[M]. 北京:化学工业出版社. 2007. [4]Lim Y, Wong NSC, Lee YY, et al. Engineering mammalian cells in bioprocessing-current achievements and future perspectives[J]. Biotechnology and Applied Biochemistry, 2010, 55(4):175-189. [5]Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture[J]. Curr Opin Biotechnol, 2001, 12:180-187. [6]Birch JR, Racher AJ. Antibody production[J]. Adv Drug Deliv Rev, 2006, 58:671-685. [7]范里, 赵亮, 孙亚婷, 等. 表达TNFR-Fc融合蛋白的GS-CHO细胞动态流加培养过程的设计[J]. 生物工程学报, 2010, 26(2):216-222. [8]Li J, Wong CL, Vijayasankaran N, et al. Feeding lactate for CHO cell culture processes:Impact on culture metabolism and performance[J]. Biotechnology and Bioengineering, 2012, 109(5):1173-1186. [9]Kshirsagar R, McElearney K, Gilbert A, et al. Controlling trisulfide modification in recombinant monoclonal antibody produced in fed‐batch cell culture[J]. Biotechnology and Bioengineering, 2012, 109(10):2523-2532. [10] Gilbert A, McElearney K, Kshirsagar R, et al. Investigation of met-abolic variability observed in extended fed batch cell culture[J]. Biotechnology Progress, 2013, 29(6):1519-1527. [11] Berrios J, Altamirano C, Osses N, et al. Continuous CHO cell cultures with improved recombinant protein productivity by using mannose as carbon source:Metabolic analysis and scale-up simulation[J]. Chemical Engineering Science, 2011, 66(11):2431-2439. [12] Garcia-Ochoa F, Gomez E. Bioreactor scale-up and oxygen transfer rate in microbial processes:an overview[J]. Biotechnology Advances, 2009, 27(2):153-176. [13] Martínez VS, Dietmair S, Quek LE, et al. Flux balance analysis of CHO cells before and after a metabolic switch from lactate produc-tion to consumption[J]. Biotechnology and Bioengineering, 2013, 110(2):660-666. [14] Takuma S, Hirashima C, Piret JM. Dependence on glucose limita-tion of the pCO2 influences on CHO cell growth, metabolism and IgG production[J]. Biotechnology and Bioengineering, 2007, 97(6):1479-1488. [15] Xing Z, Kenty BM, Li ZJ, et al. Scale-up analysis for a CHO cell culture process in large-scale bioreactors[J]. Biotechnology and Bioengineering, 2009, 103(4):733-746. [16]Takuma S, Hirashima C, Piret JM. Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production[J]. Biotechnology and Bioengineering, 2007, 97(6):1479-1488. [17]Gray DR, Chen S, Howarth W, et al. CO2 in large-scale and high-density CHO cell perfusion culture[J]. Cytotechnology, 1996, 22(1-3):65-78. [18] Kimura R, Miller WM. Effects of elevated pCO2 and/or osmolality on the growth and recombinant tPA production of CHO cells[J]. Biotechnology and Bioengineering, 1996, 52(1):152-160. [19] Goudar CT, Matanguihan R, Long E, et al. Decreased pCO2 accumulation by eliminating bicarbonate addition to high cell-density cultures[J]. Biotechnology and Bioengineering, 2007, 96(6):1107-1117. [20] 马爱瑛, 周栋, 李敏. CHO 工程细胞株低血清培养的初探[J]. 生物技术通报, 2009(11):154-157. |